Observe Medical secures first significant UnoMeter[(TM)] Safeti[(TM)] Plus orders across multiple key countries
Oslo, November 25th, 2024 – Only 1 week after launching UnoMeter(TM) Safeti(TM) Plus at MEDICA trade fair, Observe Medical ("the Company" or "Observe Medical") has received orders from Spain, Germany, Austria, Nordics, Switzerland, Baltics, Croatia and UAE with a total net sales value of NOK 3.5 million.
The initial orders from these countries represent a market potential of NOK 95 million in annual recurring revenue, based on the historical sales performance of UnoMeter(TM) Safeti(TM) Plus. This corresponds to 45% of the product’s total historic annual revenue.
These orders mark a significant milestone for the Company, advancing its goal of capitalizing on the UnoMeter(TM) Portfolio's market potential. Additionally, they lay the groundwork for future growth by establishing a robust distribution platform, supporting upcoming product launches, not least our strategically important digital solution, UnoMeter(TM) Sippi.
Jørgen Mann, CEO of Observe Medical, commented, "The fact that we only 1 week after the launch of UnoMeter(TM) Safeti(TM) Plus at MEDICA trade fair have orders from several major countries that combined have a significant value, is a confirmation of our expectation, that there is a clear market need for our solutions. It is our impression that no other products have been able to step into the space that was made vacant when UnoMeters(TM) left the market some 2 years ago. The orders vary in size, but they all represent the distributors ambitions to take back the historic market share of the UnoMeter(TM) products”.
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells innovative medtech products for the global market. The Company is committed to improving patient welfare and patient outcomes, improving clinical data accuracy and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and commercialization of its broad portfolio of medical technology products, mainly in urine measurement and ultrasound, in combination with targeted M&A and distribution. Observe Medical is working with a network of leading distributors to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.